Results 131 to 140 of about 28,133 (254)

Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE [PDF]

open access: yes, 2002
Background Enoxaparin treatment is associated with a 20% reduction in clinical events during the acute phase of management of patients with unstable angina/non ST elevation myocardial infarction.
TIMI 11B ESSENCE Investigators   +6 more
core   +1 more source

Impact of Prehospital Ticagrelor Loading Dose Combined With Aspirin Dual Antiplatelet Therapy on Post‐PCI TIMI Flow Grade in Patients With ST‐Elevation Myocardial Infarction

open access: yesClinical Cardiology, Volume 49, Issue 8, August 2026.
Graphical summary of prehospital versus in‐hospital ticagrelor plus aspirin in STEMI patients undergoing primary PCI. Prehospital dual antiplatelet therapy improved reperfusion and reduced 30‐day major adverse cardiovascular events without increasing major bleeding.
Pingwei Liu   +3 more
wiley   +1 more source

Association Between GRACE Score and Right Ventricular Function Assessed by 3D Echocardiography in Patients With Acute Inferior STEMI Undergoing Primary PCI: A Pilot Study

open access: yesHealth Science Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Objective This pilot study aimed to explore the association between the GRACE score and right ventricular (RV) function, including ejection fraction, volumes, and stroke volume, assessed using three‐dimensional echocardiography in patients with acute inferior STEMI undergoing primary PCI.
Hedieh Alimi   +4 more
wiley   +1 more source

TIMI risk score: does it work equally well in both males and females? [PDF]

open access: yes, 2007
OBJECTIVE: The TIMI (Thrombolysis In Myocardial Infarction) risk score is a seven item risk stratification tool derived from trials of patients with non-ST segment elevation acute coronary syndromes (ACS) that has been validated in emergency department ...
Follansbee, Christopher   +6 more
core  

Factor XI Inhibition for Ischemic Stroke Secondary Prevention: Pharmacology, Clinical Evidence, and Future Directions

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.
Abstract Ischemic stroke remains a leading cause of death and disability worldwide, and bleeding (particularly intracranial hemorrhage) continues to limit conventional antithrombotic therapy in secondary prevention, even with direct oral anticoagulants.
Federica Ferrari, Roberto Federico Villa
wiley   +1 more source

Multikulturni timi

open access: yes, 2019
Vse hitrejša globalizacija in širjenje podjetij na tuje trge vpliva na vse večjo število in nujnost po multikulturnih timih. Multikulturni timi se v podjetju lahko pojavljajo v različnih oblikah na primer kot simbolični, bi-kulturni ali multikulturni timi.
openaire   +1 more source

Risk Stratification in Cardiovascular Medicine for Prognostic Assessment and Therapeutic Decision‐Making: From Atrial Fibrillation to the Broader Disease Spectrum

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
Risk stratification using validated scoring systems plays a significant role in contemporary cardiovascular medicine not only for prognostic assessment but also for treatment optimization, resource allocation, and shared decision‐making. Beyond accurate prognostication, whether the use of a risk score can aid clinical decision‐making and improve ...
Yuichi Saito   +4 more
wiley   +1 more source

Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment

open access: yesMedComm, Volume 7, Issue 8, August 2026.
This visual summary illustrates the key aspects of coronary microvascular dysfunction (CMD) in angina with nonobstructive coronary artery disease (NOCAD), including epidemiology, pathophysiology (microvascular remodeling and endothelial dysfunction), the protective NRG‐1/ErbB signaling pathway, diagnostic methods, and both Western and traditional ...
Zhao Ge   +8 more
wiley   +1 more source

A Systems Pharmacology Model of Aging Identifies Optimal Combination Therapies With Secondary Benefits on Weight Loss and Metabolic Health

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 8, August 2026.
ABSTRACT Aging is a systems‐level process linking metabolic dysfunction, inflammation, impaired repair, frailty, and multimorbidity, whereas existing pharmacological strategies usually optimize disease‐specific endpoints such as weight loss or HbA1c rather than aging‐related trajectories. We developed an SBML‐compliant quantitative systems pharmacology
Igor Goryanin, Bob Damms, Irina Goryanin
wiley   +1 more source

Heterosentis martini Lanfranchi & Timi 2011

open access: yes, 2012
Published as part of Lunaschi, Lia I., Álvarez, Victor Hugo Merlo & Damborenea, Cristina, 2012, Type material housed in the Helminthological Collection of the Museo de La Plata, Buenos Aires, Argentina, pp.
Lunaschi, Lia I.   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy